Description
Overview of Unifiram
Unifiram (DM232) is a synthetic experimental chemical that shares structural similarities with piracetam. Its pharmacological profile and mechanistic effects on neuronal signaling pathways have been investigated. As one of several racetam-like compounds, Unifiram is studied in laboratories using regulated in vitro and ex vivo models, with an emphasis on how it interacts with the cholinergic and glutamatergic systems. It is important to note that this chemical is supplied for research purposes only.
Chemical and Molecular Properties
| Unifiram | |
| PubChem CID | 9861054 |
| Molecular Formula | C13H15FN2O3S |
| Molecular Weight | 298.34 g/mol |
| Synonyms | UNII-N4024LN29G
DTXSID00432024 |
| IUPAC | 2-(4-fluorophenyl)sulfonyl-1,3,4,7,8,8a-hexahydropyrrolo[1,2-a]pyrazin-6-one |
| CAS | 272786-64-8 |
| Labeling | Research Use Only (RUO), not for human or animal consumption. |
| Chemical Structure Depiction |
|
| Purity | ≥98% |
| Classification | Research Use Only (RUO) |
| Storage Temperature | 2–8 °C recommended; protect from light |
| Solubility | Soluble in DMSO and research‑grade organic solvents |
| Safety | Handle with gloves, a lab coat, eye protection; use a fume hood if dust/aerosol is possible |
Various Mechanisms of Unifiram
Modulation of AMPA-Dependent Synaptic Signaling
Preclinical studies using hippocampal slice preparations show that Unifiram can increase field excitatory postsynaptic potential (fEPSP) amplitudes, implicating AMPA-type glutamate receptor pathways in its mechanistic profile. These effects are examined in laboratory models to understand how excitatory synaptic transmission can be indirectly enhanced
Lack of Direct Classic Receptor Activation
Binding studies in controlled experimental models demonstrate that Unifiram (DM232) does not interact significantly with common neurotransmitter receptors or ion channels at tested in vitro concentrations. These findings indicate that the observed modulation of synaptic activity occurs through indirect mechanisms rather than classic receptor agonism or antagonism
Cholinergic Release Modulation
In experimental cortical tissue models, Unifiram has been reported to enhance acetylcholine release, demonstrating modulation of cholinergic pathways in neural circuits. These effects are studied in controlled preclinical models to explore neurotransmitter dynamics without direct receptor binding
Unifiram Research Applications
Unifiram is principally utilized in research contexts to study molecular and cellular mechanisms associated with excitatory neurotransmission and synaptic plasticity. Preclinical and in vitro research applications include:
- Exploration of glutamatergic synaptic signaling pathways using electrophysiological recordings.
- Investigation of acetylcholine release dynamics and cholinergic modulation in isolated neural tissues.
- Characterization of indirect synaptic modulators that affect fEPSP amplitude in hippocampal slice assays.
- Structure‑activity relationship research for novel analogues of DM232 and related investigational ligands.
Research usage focuses on mechanistic understanding of neural signaling pathways in controlled experimental models rather than effects in clinical populations. Unifiram is currently under investigation and has not been approved by the FDA. It is exclusively granted for the purpose of research only.
Why Choose Purerawz for Unifiram?
Buy Unifiram for laboratory research use from our online shop. At Purerawz, we provide high-quality reference materials. Each research compound comes with a Certificate of Analysis for verification of purity and concentration.
Note:
Unifiram is an investigational compound currently undergoing clinical evaluation and has not been established as safe or effective for any therapeutic use
Disclaimer
This information is for educational purposes only and not medical advice. Products are for research use only. Research must follow IRB or IACUC guidelines. Verify information independently before purchasing. By ordering, you agree to our Terms and Conditions. If you are not 100% satisfied with the product you received, please contact us at support@staging.purerawz.co
ATTENTION: All our products are for LABORATORY AND RESEARCH PURPOSES ONLY, not for veterinary or human use
Reference Links
Galeotti N., Ghelardini C., Pittaluga A., et al. AMPA‑receptor activation is involved in the antiamnesic effect of DM232 (unifiram) and DM235 (sunifiram). Naunyn Schmiedebergs Archives of Pharmacology. 368(6):538–545. https://pubmed.ncbi.nlm.nih.gov/14600801/
Romanelli M. N., Galeotti N., Ghelardini C., et al. Pharmacological Characterization of DM232 (Unifiram) and DM235 (Sunifiram), New Potent Cognition Enhancers. CNS Drug Reviews, 12(1):39–52. https://pubmed.ncbi.nlm.nih.gov/16834757/
Scapecchi S., Martini E., Manetti D., et al. Structure–activity relationship studies on unifiram (DM232) and sunifiram (DM235), two novel and potent cognition enhancing drugs. Bioorganic & Medicinal Chemistry. 12(1):71–85. https://pubmed.ncbi.nlm.nih.gov/14697772/
PubChem Compound Summary for Unifiram (CAS 272786–64–8). National Center for Biotechnology Information, U.S. National Library of Medicine. https://pubchem.ncbi.nlm.nih.gov/compound/Unifiram
Dr. Helma Wennemers
Dr. Helma Wennemers is a globally recognized chemist shaping modern peptide science and molecular design through highly original research in applied biosciences.
Her work explores how precise molecular architecture can be engineered to create new functional systems in chemistry and life sciences. Her contributions continue to redefine contemporary chemical research through creativity, depth, and structural innovation.

